journal article·2024-06

Plaque‐Specific Adhesive Balloons Coated with Calcium Phosphate Nanoparticles Loaded with Rapamycin for Atherosclerosis Therapy

Yun Xiao, Jun Lin, Yanbo Zhao, Xiaoyu Wang, Qingbo Lv, Wujiao Li, Ruikang Tang, Guosheng Fu

Advanced Functional Materials· Volume 34· Issue 24
Publisher page

Abstract

Abstract Drug‐coated balloons (DCBs), serving as a superior alternative to stents, are at the cutting edge of clinical innovations in atherosclerosis management. Nevertheless, the prevalent high flow rates in arterial vascular result in short drug residence times, significantly compromising DCBs’ therapeutic effectiveness. Drawing inspiration from the mechanisms of vascular calcification, a rapamycin‐loaded calcium phosphate nanoparticle (CaP@Rapa) coating for balloons is pioneered. This coating functions as a potent drug anchor in arteries, facilitating the adhesion of rapamycin to plaques and thereby enhancing the local concentration of the rapamycin. To evaluate its therapeutic efficacy in vivo, the rabbit iliac artery atherosclerosis model is innovatively developed, which authentically mirrors the pathological progression of atherosclerosis in humans. The enhanced localized rapamycin retention, along with its pH‐sensitive sustained release characteristics, culminate in substantial reductions in plaque volume, a decrease in intimal hyperplasia, and mitigation of local inflammation in model rabbits. To further substantiate the translational potential of CaP@Rapa balloons, the research on the pig coronary atherosclerosis model is expanded, which yielded results solidifying the clinical promise of CaP@Rapa balloons. In summary, this research not only offers a more effective and reliable alternative to traditional DCB but also paves the way for further clinical trials.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Coronary Interventions and Diagnostics · Aortic aneurysm repair treatments · Protease and Inhibitor Mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province Department of Cardiology Sir Run Run Shaw Hospital Zhejiang University School of Medicine Hangzhou 310016 China

Department of Cardiovascular Surgery Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou 510120 China

Qiushi Academy for Advanced Studies Zhejiang University Hangzhou 310058 China

Department of Chemistry Zhejiang University Hangzhou 310058 China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Zhejiang Province

References (46)

Show source-provided references
1. 10.1038/3502520310.1038/35025203 ↗
2. Libby P. · Circulation · 2002 · 105 · 9
3. 10.1016/j.jacc.2021.01.03810.1016/j.jacc.2021.01.038 ↗
4. 10.1056/NEJMoa080462610.1056/NEJMoa0804626 ↗
5. Ullrich H. · DTSCH Arztebl. Int. · 2022 · 118 · 38
6. 10.1016/j.jcmg.2018.12.02110.1016/j.jcmg.2018.12.021 ↗
7. 10.1056/NEJMoa140623510.1056/NEJMoa1406235 ↗
8. 10.1146/annurev-bioeng-071813-10525910.1146/annurev-bioeng-071813-105259 ↗
9. 10.1016/j.pharmthera.2010.11.00310.1016/j.pharmthera.2010.11.003 ↗
10. Leopold J. A. · Trends Cardiovasc. Med. · 2015 · 25 · 4
11. 10.1016/S1936-8798(18)30559-410.1016/S1936-8798(18)30559-4 ↗
12. 10.1093/cvr/cvy01010.1093/cvr/cvy010 ↗
13. 10.1093/eurheartj/ehu16310.1093/eurheartj/ehu163 ↗
14. 10.1161/CIRCRESAHA.108.18130510.1161/CIRCRESAHA.108.181305 ↗
15. 10.1016/j.cis.2019.04.01110.1016/j.cis.2019.04.011 ↗
16. 10.1016/j.actbio.2009.07.02310.1016/j.actbio.2009.07.023 ↗
17. 10.1038/s41569-018-0105-x10.1038/s41569-018-0105-x ↗
18. 10.1194/jlr.R05025210.1194/jlr.R050252 ↗
19. 10.1016/j.carbpol.2014.04.08210.1016/j.carbpol.2014.04.082 ↗
20. 10.1038/nnano.2016.7210.1038/nnano.2016.72 ↗
21. 10.1172/JCI6767410.1172/JCI67674 ↗
22. Pan H. H. · Chem. Commun. · 2010 · 46 · 39
23. Lei J. S. · Adv. Funct. Mater. · 2022 · 32 · 30
24. 10.1016/j.cis.2019.04.01110.1016/j.cis.2019.04.011 ↗
25. 10.1016/j.cej.2010.02.00610.1016/j.cej.2010.02.006 ↗
26. Millington B. · J. Power Sources · 2011 · 196 · 20
27. 10.1111/eci.1240710.1111/eci.12407 ↗
28. 10.1161/CIRCRESAHA.112.27145210.1161/CIRCRESAHA.112.271452 ↗
29. 10.1074/jbc.M90917419910.1074/jbc.M909174199 ↗
30. 10.3892/mmr.2017.684410.3892/mmr.2017.6844 ↗
31. 10.1002/jcb.2141110.1002/jcb.21411 ↗
32. 10.2217/nnm-2015-000710.2217/nnm-2015-0007 ↗
33. 10.1161/CIRCULATIONAHA.104.50893710.1161/CIRCULATIONAHA.104.508937 ↗
34. 10.1161/CIRCINTERVENTIONS.108.78997410.1161/CIRCINTERVENTIONS.108.789974 ↗
35. 10.1111/apha.1246610.1111/apha.12466 ↗
36. 10.1016/j.cell.2017.02.00410.1016/j.cell.2017.02.004 ↗
37. 10.1161/CIRCRESAHA.117.31114710.1161/CIRCRESAHA.117.311147 ↗
38. 10.1161/CIRCRESAHA.113.30204910.1161/CIRCRESAHA.113.302049 ↗
39. Li J. · J. Healthc. Eng. · 2022
40. 10.1089/ars.2009.287510.1089/ars.2009.2875 ↗
41. 10.1161/01.RES.0000229683.81357.2610.1161/01.RES.0000229683.81357.26 ↗
42. 10.1016/0021-9150(95)05515-X10.1016/0021-9150(95)05515-X ↗
43. 10.5551/jat1994.1.5310.5551/jat1994.1.53 ↗
44. 10.1042/CS2018030610.1042/CS20180306 ↗
45. 10.1016/j.immuni.2016.02.01510.1016/j.immuni.2016.02.015 ↗
46. Zaragoza C. · J. Biomed. Biotechnol. · 2011